It is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies.
One 250mg tablet with or without food. For patients who have difficulty swallowing solids: Tablets can also be dispersed in half a glass of driniking water.
Hepatotoxicity, Patients with Hepatic Impairment, Pregnancy, Nursing Mother, Pediatrics Use,Severe renal impairment.
Diarrhea, rash, acne, dry skin, nausea, and vomiting. The 500mg dose showed a higher rate for most of these adverse events.
|Brand Name||Manufactured by|
|GEFF||INTAS PHARMACEUTICALS LTD.|
|GEFITAX||BRUCK PHARMA PVT.LTD|
|GEFITAX||TAXANE HEALTHCARE PVT. LTD.|
|GEFONIB||MIRACALUS PHARMA PVT. LTD.|
|GEFTIGET||GLS PHARMA LTD|
|GEFTINAT||NATCO PHARMA LTD.|
|GTNIB||BIOCARE (Div. of Health biotech Ltd.)|
|O-GNAT||SAIN MEDICAMENT PVT. LTD.|
|TYROGEF||Sun Pharmaceutical Industries Ltd.|
|ZEFINIB||ZUVIUS LIFE SCIENCES|
|ZEFTIGLO||GLOBELA PHARMA PVT. LTD.|